Nathalie Nicolaiew

Université Paris Est, UMR_S955
Creteil, 94000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

The Neuropilin-1/PKC axis promotes neuroendocrine differentiation and drug resistance of prostate cancer.

The Neuropilin-1/PKC axis promotes neuroendocrine differentiation and drug resistance of prostate cancer.

Journal: British journal of cancer

Published: January 14, 2020

Erratum: CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities.

Erratum: CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities.

Journal: Oncotarget

Published: July 11, 2019

Not Available

Not Available

Journal: Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie

Published: November 07, 2015

Not Available

Not Available

Journal: Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie

Published: October 14, 2015

Not Available

Not Available

Journal: Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie

Published: October 14, 2015

Clinical value of ERG, TFF3, and SPINK1 for molecular subtyping of prostate cancer.

Clinical value of ERG, TFF3, and SPINK1 for molecular subtyping of prostate cancer.

Journal: Cancer

Published: August 28, 2014

CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities.

CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities.

Journal: Oncotarget

Published: August 15, 2014

Left lobe of the prostate during clinical prostate cancer screening: the dark side of the gland for right-handed examiners.

Left lobe of the prostate during clinical prostate cancer screening: the dark side of the gland for right-handed examiners.

Journal: Prostate cancer and prostatic diseases

Published: November 02, 2013

Risk of repeat biopsy and prostate cancer detection after an initial extended negative biopsy: longitudinal follow-up from a prospective trial.

Risk of repeat biopsy and prostate cancer detection after an initial extended negative biopsy: longitudinal follow-up from a prospective trial.

Journal: BJU international

Published: March 05, 2013

Cross modulation between the androgen receptor axis and protocadherin-PC in mediating neuroendocrine transdifferentiation and therapeutic resistance of prostate cancer.

Cross modulation between the androgen receptor axis and protocadherin-PC in mediating neuroendocrine transdifferentiation and therapeutic resistance of prostate cancer.

Journal: Neoplasia (New York, N.Y.)

Published: December 08, 2012

Prediction of the risk of harboring prostate cancer by a prebiopsy nomogram based on extended biopsy protocol.

Prediction of the risk of harboring prostate cancer by a prebiopsy nomogram based on extended biopsy protocol.

Journal: Urologia internationalis

Published: May 25, 2012

Prospective evaluation of an extended 21-core biopsy scheme as initial prostate cancer diagnostic strategy.

Prospective evaluation of an extended 21-core biopsy scheme as initial prostate cancer diagnostic strategy.

Journal: European urology

Published: April 01, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026